Evidence map›Paper›PMID 19640960›Full record

Trial reportThe American journal of clinical nutrition2009

Alcohol consumption and diabetes risk in the Diabetes Prevention Program.

Jill P Crandall, Sarit Polsky, Andrea A Howard, Leigh Perreault, George A Bray, Elizabeth Barrett-Connor, Janet Brown-Friday, Tracy Whittington, Sandra Foo, Yong Ma and 2 more

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The American journal of clinical nutrition, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT00038727. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00038727 phase3completed

Diabetes Prevention Program Outcomes Study

Ran1996Enrolled2,779Registered outcomes17Posted comparisons2ConditionsCancer, CVD, Diabetes MellitusArmsDPPOS Boost Lifestyle, DPPOS Group Lifestyle, Intensive Lifestyle Group Session, Metformin
PMID 19878986PMID 26377054PMID 11832527other papers from this trial
Open the trial in the graph
3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Alcohol and Metabolic-associated Fatty Liver Disease.Journal of clinical and translational hepatology · 2021
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Observational
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jill P CrandallAlbert Einstein College of Medicine, Bronx, NY, USA. dppmail@biostat.bsc.gwu.edu
Sarit Polsky
Andrea A Howard
Leigh Perreault
George A Bray
Elizabeth Barrett-Connor
Janet Brown-Friday
Tracy Whittington
Sandra Foo
Yong Ma
Sharon L Edelstein
Diabetes Prevention Program Research Group

Funding

PRIMARY PREVENTION TRIAL--DATA COORDINATING CENTERU01DK048489 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI JABLONSKI, KATHLEEN ANN, TEMPROSA, MARINELLA · 1994 to 2021
$84.8M
NIDDK NIH HHS U01 DK048489
6 · The paper itself

Abstract

backgroundModerate alcohol consumption is associated with a decreased risk of type 2 diabetes in the general population, but little is known about the effects in individuals at high risk of diabetes.

objectivesThe objectives were to determine associations between alcohol consumption and diabetes risk factors and whether alcohol consumption was a predictor of incident diabetes in individuals enrolled in the Diabetes Prevention Program (DPP).

designDPP participants (n = 3175) had impaired glucose tolerance (2-h glucose: 7.8-11.1 mmol/L), elevated fasting glucose (5.3-7.0 mmol/L), and a body mass index (in kg/m(2)) > or =24. Participants were randomly assigned to placebo, metformin, or lifestyle modification and were followed for a mean of 3.2 y. Alcohol intake was assessed at baseline and year 1 by using a semiquantitative food-frequency questionnaire. Diabetes was diagnosed by annual oral-glucose-tolerance testing and semiannual fasting plasma glucose measurement.

resultsParticipants who reported higher alcohol consumption tended to be male, older, white, and less obese and to have a higher calorie intake and a higher HDL-cholesterol concentration. Higher alcohol consumption was associated with lower insulin secretion at any level of insulin sensitivity. We found lower incidence rates of diabetes with higher alcohol consumption in the metformin (P < 0.01 for trend) and lifestyle modification (P = 0.02 for trend) groups, which remained significant after adjustment for multiple baseline covariates. No similar association was observed in the placebo group.

conclusionsDespite overall low rates of alcohol consumption, there was a reduced risk of incident diabetes in those who reported modest daily alcohol intake and were assigned to metformin or lifestyle modification. Moderate daily alcohol intake is associated with lower insulin secretion-an effect that warrants further investigation. This trial was registered at clinicaltrials.gov as NCT00038727.

Indexed as

Alcohol DrinkingHealth BehaviorLife StyleAdultAgedAged, 80 and overCholesterol, HDLDiabetes Mellitus, Type 2Energy IntakeFemaleGlucose IntoleranceGlucose Tolerance TestHumansHyperglycemiaHypoglycemic AgentsIncidenceCholesterol, HDLHypoglycemic AgentsInsulinMetforminPlacebos

Identifiers

PMID19640960
PMCPMC2728644

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.